A detailed history of Tcw Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Tcw Group Inc holds 276,727 shares of AMGN stock, worth $73.1 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
276,727
Previous 276,727 -0.0%
Holding current value
$73.1 Million
Previous $89.2 Million -0.0%
% of portfolio
0.8%
Previous 0.8%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $5.25 Million - $5.73 Million
16,984 Added 6.54%
276,727 $89.2 Million
Q2 2024

Jul 18, 2024

BUY
$262.75 - $319.31 $15.9 Million - $19.3 Million
60,542 Added 30.39%
259,743 $81.2 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $6.54 Million - $7.89 Million
24,310 Added 13.9%
199,201 $56.6 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $8.96 Million - $10.1 Million
35,040 Added 25.06%
174,891 $50.4 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $4.98 Million - $6.18 Million
-22,774 Reduced 14.0%
139,851 $37.6 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $2.63 Million - $3.11 Million
12,294 Added 8.18%
162,625 $36.1 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $1.88 Million - $2.29 Million
8,321 Added 5.86%
150,331 $36.3 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $2.65 Million - $3.37 Million
11,585 Added 8.88%
142,010 $37.3 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $3.6 Million - $4.06 Million
16,049 Added 14.03%
130,425 $29.4 Million
Q2 2022

Jul 19, 2022

BUY
$230.71 - $256.74 $12.5 Million - $13.9 Million
54,015 Added 89.49%
114,376 $27.8 Million
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $13.2 Million - $14.6 Million
60,361 New
60,361 $14.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.